Journal of Clinical Epidemiology
Volume 58, Issue 6 , Pages 624-628 , June 2005

Preferred provider organization claims showed high predictive value but missed substantial proportion of adults with high-risk conditions

  • Faruque Ahmed

      Affiliations

    • Division of Prevention Research and Analytic Methods, Epidemiology Program Office, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Mail Stop K53, Atlanta, GA 30341-3717, USA
    • Corresponding Author InformationCorresponding author. Tel.: 770-488-3005; fax: 770-488-4759.
    • ,
  • Gail R. Janes

      Affiliations

    • Division of Prevention Research and Analytic Methods, Epidemiology Program Office, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Mail Stop K53, Atlanta, GA 30341-3717, USA
    • ,
  • Roy Baron

      Affiliations

    • Division of Prevention Research and Analytic Methods, Epidemiology Program Office, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Mail Stop K53, Atlanta, GA 30341-3717, USA
    • ,
  • Lisa M. Latts

      Affiliations

    • Department of Obstetrics and Gynecology, University of Colorado Health Science Center, 1635 N Ursula St, MS F711, Denver, CO 80010 USA
    • ,
  • the Colorado Anthem Blue Cross and Blue Shield Study Team

      Affiliations

    • Laura Kauffman, MSPH, Mary Hothem, RN.

,Accepted 15 November 2004.

References 

  1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–186
  2. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis. 2000;181:831–837
  3. Centers for Disease Control and Prevention . Prevention and control of influenza: recommendations of the Advisory Committee on Influenza Practices (ACIP). MMWR. 2003;52(No. RR-8):1–34
  4. Nichol K. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med. 2001;161:749–759
  5. Centers for Disease Control and Prevention . Update: Influenza activity—United States, 2003–04 season. MMWR. 2003;52(49):1197–1202
  6. Delayed influenza vaccine availability for 2001–02 season and supplementary recommendations of the Advisory Committee on Immunization Practices. MMWR. 2001;50:582–585
  7. Updated recommendations from the Advisory Committee on Immunization Practices in response to delays in supply of influenza vaccine for the 2000–01 season. MMWR. 2000;49:888–892
  8. Greenberg L. PPO performance measurement: agenda for the future. Med Care Res Rev. 2001;58(Suppl 1):8–15
  9. U.S. Department of Health and Human Services, Public Health Service . International classification of diseases, 9th rev., Clinical modification. Washington, DC: U.S. Government Printing Office; Publication (PHS) 80-1260; 1980;
  10. Neuzil KM, Reed GW, Mitchel EF, Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA. 1999;281:901–907
  11. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med. 1982;142:85–89
  12. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112:798–813
  13. Fedson DS, Wajda A, Nicol JP, et al. Clinical effectiveness of influenza vaccination in Manitoba. JAMA. 1993;270:1956–1961
  14. Hak E, Nordin J, Wei F, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis. 2002;35:370–377
  15. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001;184:665–670
  16. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 1998;158:1769–1776
  17. Nichol KL, Margolis KL, Wuorenma J, von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778–784
  18. Neuzil KM, Wright PF, Mitchel EF, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr. 2000;137:856–864
  19. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225–231
  20. Ernst JMP. Who is at risk for influenza? Using criteria other than age. Managed Care. 2000;October:46–55
  21. Altman DG. Practical statistics for medical research. London, UK: Chapman and Hall; 1991;p.403–13
  22. Vassarstats. Bayes' theorem: conditional probabilities. Available at: http://faculty.vassar.edu/lowry/bayes.html. Accessed December 30, 2003.
  23. Jollis JG, Ancukiewicz M, DeLong ER, et al. Discordance of databases designed for claims payment versus clinical information systems: implications for outcomes research. Ann Intern Med. 1993;119:844–850
  24. Raiford DS. Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan hospital automated database. Epidemiology. 1996;7:101–104
  25. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57:131–141
  26. Daley MF, Barrow J, Pearson K, Crane LA, Gao D, Stevenson JM, et al. Identification and recall of children with chronic medical conditions for influenza vaccination. Pediatrics. 2004;113:e26–e33

PII: S0895-4356(04)00369-5

doi: 10.1016/j.jclinepi.2004.11.020

Journal of Clinical Epidemiology
Volume 58, Issue 6 , Pages 624-628 , June 2005

Article Tools